-
2026
- 2026
-
Relocated PHABIOS Co. to the New Head Office
-
Launched 'NAD Tablet'
-
2025
- 2025
-
Joint patent registration for a smart drug-delivery composition with Yeungnam University College.
-
PHABIOS Co. opens a new homepage.
-
PHABIOS Co. has introduced a new CI(Corporate Identity).
-
Patent license agreement with Keimyung University for the production of mesoporous silica using natural surfactants.
-
Joint patent registration for skin drug-releasing hydrogels with
Yeungnam University College.
-
2024 ~ 2021
- 2024
- PHABIOS Co. selected for the SME Direct Support Program for New Brand Development.
- Relocation of PHABIOS Co.’s R&D Department to Keimyung University Techno Park
- Relocation of ‘NC Bioscience Co., Ltd.(Research Institute)’ to Kyungpook National University
- Technology Transfer to NC Bioscience Co., Ltd.: Know-How for Developing a Micro-Well Array–Based Real-Time Imaging System from Sogang University
- NC Bioscience Co., Ltd. selected for the Ministry of SMEs and Startups’ Startup Growth Technology Development (Stepping-Stone) Program (Project: Development of a Microfluidic Chip for Microplastic Detection)
- Launched ‘V-THREE Inj.’
- 2023
- Joint patent registration for wet band composition, wet band and its manufacturing method with Yeungnam University College
- Technology transfer in wound-dressing materials acquired from Sogang University and Yeungnam University College
- Joint patent application with Yeungnam University College for a smart drug-delivery composition
- Launched ‘SEROLZIN Tab.’
- 2022
- PHABIOS Co. incorporated as a corporate entity
- Joint patent application with Yeungnam University College related to wet bands
- Acquired a technology transfer from Daegu Haany University for core-shell hydrogel microcapsule manufacturing
- Received certification as an R&D center recognized by the Ministry of Science and ICT
- Established the NC Bioscience Co.,Ltd. Research Institute
- Launched ‘DTC Cap.’
- 2021
- Designated as a “Venture Enterprise” by the Ministry of SMEs and Startups
- Signed an MOU with Ajou University
- Joint patent application with Sogang University and Yeungnam University College
- Consignment business for disease susceptibility genetic testing
-
2020 ~ 2018
- 2020
- Launched ‘GLCHION Tab.’
- 2019
- Launched ‘ MESIMA®-F’
- 2018
- Founded PHABIOS Co.
- Launched ‘ZEMBIO Capsule’
- Launched ‘POLYERGA Tablets ‘
- Consignment business for MammaPrint Genome Test(Agendia)